189 related articles for article (PubMed ID: 19204913)
21. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
22. Parthenolide inhibits human lung cancer cell growth by modulating the IGF‑1R/PI3K/Akt signaling pathway.
Sun L; Yuan W; Wen G; Yu B; Xu F; Gan X; Tang J; Zeng Q; Zhu L; Chen C; Zhang W
Oncol Rep; 2020 Sep; 44(3):1184-1193. PubMed ID: 32705224
[TBL] [Abstract][Full Text] [Related]
23. Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells.
Li S; Gao X; Wu X; Wu Z; Cheng L; Zhu L; Shen D; Tong X
Acta Biochim Biophys Sin (Shanghai); 2015 May; 47(5):368-75. PubMed ID: 25841439
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin siRNA does not confer resistance to toxic effects of parthenolide in Jurkat cells.
Mehri S; Mohammadi S; Nikbakht M; Sahmani M; Zahedpanah M
Exp Oncol; 2020 Sep; 42(3):188-191. PubMed ID: 32996731
[TBL] [Abstract][Full Text] [Related]
25. Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Liu M; Yang Y; Liu D; Cao Y; Li Y
J Tradit Chin Med; 2020 Dec; 40(6):908-916. PubMed ID: 33258341
[TBL] [Abstract][Full Text] [Related]
26. Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.
Morel KL; Ormsby RJ; Bezak E; Sweeney CJ; Sykes PJ
Radiat Res; 2017 May; 187(5):501-512. PubMed ID: 28398879
[TBL] [Abstract][Full Text] [Related]
27. Parthenolide Has Negative Effects on In Vitro Enhanced Osteogenic Phenotypes by Inflammatory Cytokine TNF-α via Inhibiting JNK Signaling.
Park JH; Kang YH; Hwang SC; Oh SH; Byun JH
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751648
[TBL] [Abstract][Full Text] [Related]
28. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
29. Genomic profiling of tumor initiating prostatospheres.
Duhagon MA; Hurt EM; Sotelo-Silveira JR; Zhang X; Farrar WL
BMC Genomics; 2010 May; 11():324. PubMed ID: 20500816
[TBL] [Abstract][Full Text] [Related]
30. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.
Zhang K; Waxman DJ
Mol Cancer; 2010 Dec; 9():319. PubMed ID: 21190562
[TBL] [Abstract][Full Text] [Related]
31. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
[TBL] [Abstract][Full Text] [Related]
32. Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells.
Chen W; Li P; Liu Y; Yang Y; Ye X; Zhang F; Huang H
J Exp Clin Cancer Res; 2018 Dec; 37(1):309. PubMed ID: 30541589
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
34. Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts.
Ren Y; Li Y; Lv J; Guo X; Zhang J; Zhou D; Zhang Z; Xue Z; Yang G; Xi Q; Liu H; Liu Z; Zhang L; Zhang Q; Yao Z; Zhang R; Da Y
J Cell Biochem; 2019 Sep; 120(9):15695-15708. PubMed ID: 31144365
[TBL] [Abstract][Full Text] [Related]
35. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
[TBL] [Abstract][Full Text] [Related]
38. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
[TBL] [Abstract][Full Text] [Related]
39. Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells.
Duan D; Zhang J; Yao J; Liu Y; Fang J
J Biol Chem; 2016 May; 291(19):10021-31. PubMed ID: 27002142
[TBL] [Abstract][Full Text] [Related]
40. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
